Pharmaceutical company Moderna announced Wednesday it will test its potential COVID-19 vaccine on children.
The study will include 3,000 kids ages 12 to 17, with half receiving two shots of the vaccine four weeks apart, and the other half getting placebo shots of salt water, the New York Times reported.
On Monday, Moderna announced it had applied for emergency use authorization with the Food and Drug Administration, and touted that its vaccine was 94 percent effective in adults during clinical trials.
A Moderna spokeswoman told the Times the company is yet to open testing sites or accept volunteers for its kids’ study.
Vaccines for adults and children are usually tested in adults first. Generally, vaccines must be tested in children before they can receive them.
Dr. Anthony Fauci said Sunday that it will be “months” before school-age kids will get a vaccine because kids are more vulnerable.
The Centers for Disease Control and Prevention announced Tuesday that health care workers and those living in long-term care facilities should be first in receiving a vaccine once one is approved.